Literature DB >> 23972873

Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients?

Robert B Raffa1, Joseph V Pergolizzi.   

Abstract

There is a curious and paradoxic phenomenon, reliably demonstrated in animal models, that consists of an increased sensitivity to pain that is apparently induced by the very opioid drugs used to ameliorate the pain. This phenomenon is termed "opioid-induced hyperalgesia." Whether opioid-induced hyperalgesia occurs in humans, and, if so, to what extent and consequence, is far less established. This is a critical question for attempting to treat pain. If opioid-induced hyperalgesia develops in a patient, it would masquerade as tolerance (because the clinical effectiveness of the opioid would be diminished), yet the appropriate clinical adjustment would be precisely the opposite to that of tolerance. It would be to decrease, rather than increase, the dose of opioid. We review the evidence, particularly the clinical evidence, about opioid-induced hyperalgesia and the postulated mechanisms. We conclude that given the clinical ramifications, opioid-induced hyperalgesia is one of the most understudied important aspects of opioid research.
Copyright © 2013 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23972873     DOI: 10.1016/j.pmn.2011.04.002

Source DB:  PubMed          Journal:  Pain Manag Nurs        ISSN: 1524-9042            Impact factor:   1.929


  8 in total

Review 1.  How to assess a new patient for a multidisciplinary chronic pain rehabilitation program: a review article.

Authors:  Adham Malaty; Josephine Sabharwal; Lesley Smallwood Lirette; Gassan Chaiban; Hazem Eissa; Reda Tolba
Journal:  Ochsner J       Date:  2014

Review 2.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

3.  The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary.

Authors:  Ajay Manhapra; Albert J Arias; Jane C Ballantyne
Journal:  Subst Abus       Date:  2017-10-18       Impact factor: 3.716

4.  Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.

Authors:  R R Edwards; A J Dolman; E Michna; J N Katz; S S Nedeljkovic; D Janfaza; Z Isaac; M O Martel; R N Jamison; A D Wasan
Journal:  Pain Med       Date:  2016-03-01       Impact factor: 3.750

Review 5.  Opioid-induced hyperalgesia in chronic pain patients and the mitigating effects of gabapentin.

Authors:  Nicoleta Stoicea; Daric Russell; Greg Weidner; Michael Durda; Nicholas C Joseph; Jeffrey Yu; Sergio D Bergese
Journal:  Front Pharmacol       Date:  2015-05-27       Impact factor: 5.810

6.  Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia.

Authors:  Folabomi A Oladosu; Matthew S Conrad; Sandra C O'Buckley; Naim U Rashid; Gary D Slade; Andrea G Nackley
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

7.  Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLECT): study protocol for a randomized controlled trial.

Authors:  Sjoerd de Hoogd; Sabine J G M Ahlers; Eric P A van Dongen; Dick Tibboel; Albert Dahan; Catherijne A J Knibbe
Journal:  Trials       Date:  2014-11-27       Impact factor: 2.279

8.  Intravenous Ibuprofen for Treatment of Post-Operative Pain: A Multicenter, Double Blind, Placebo-Controlled, Randomized Clinical Trial.

Authors:  Andrea Gago Martínez; Blanca Escontrela Rodriguez; Antonio Planas Roca; Alberto Martínez Ruiz
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.